ELCCSEast London Christian Choir School (UK)
References in periodicals archive ?
These studies are highlighted in the ELCC press programme on Friday 15 April.
Safety and efficacy data from two exploratory trials combining immunotherapies and small-molecules will be reported at ELCC. These presentations have been designated best abstracts by the conference.
At ELCC, we are presenting the exceptional science behind our combination approach with abstracts describing the ongoing MYSTIC and NEPTUNE studies combining durvalumab with tremelimumab.